Published in Psychooncology on July 10, 2013
Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research. Brain Imaging Behav (2013) 0.83
Cancer, coping, and cognition: a model for the role of stress reactivity in cancer-related cognitive decline. Psychooncology (2014) 0.82
Modifiable factors and cognitive dysfunction in breast cancer survivors: a mixed-method systematic review. Support Care Cancer (2015) 0.80
Optimism and Spontaneous Self-affirmation are Associated with Lower Likelihood of Cognitive Impairment and Greater Positive Affect among Cancer Survivors. Ann Behav Med (2016) 0.77
Relationships among attention function, exercise, and body mass index: a comparison between young breast cancer survivors and acquaintance controls. Psychooncology (2014) 0.76
Stereotype threat and the intellectual test performance of African Americans. J Pers Soc Psychol (1995) 16.31
A threat in the air. How stereotypes shape intellectual identity and performance. Am Psychol (1997) 12.54
For better or for worse: neural systems supporting the cognitive down- and up-regulation of negative emotion. Neuroimage (2004) 8.72
Self-regulation and depletion of limited resources: does self-control resemble a muscle? Psychol Bull (2000) 7.88
Ego depletion: is the active self a limited resource? J Pers Soc Psychol (1998) 7.54
High self-control predicts good adjustment, less pathology, better grades, and interpersonal success. J Pers (2004) 7.51
Relating effortful control, executive function, and false belief understanding to emerging math and literacy ability in kindergarten. Child Dev (2007) 6.90
Ego depletion and the strength model of self-control: a meta-analysis. Psychol Bull (2010) 4.84
Neural correlates of conscious self-regulation of emotion. J Neurosci (2001) 4.53
Working-memory capacity and the control of attention: the contributions of goal neglect, response competition, and task set to Stroop interference. J Exp Psychol Gen (2003) 4.42
Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol (2011) 3.69
The cognitive benefits of interacting with nature. Psychol Sci (2008) 3.62
Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy. Neurology (2011) 3.14
Stigma consciousness: the psychological legacy of social stereotypes. J Pers Soc Psychol (1999) 2.80
An integrated process model of stereotype threat effects on performance. Psychol Rev (2008) 2.73
Converging evidence that stereotype threat reduces working memory capacity. J Pers Soc Psychol (2003) 2.39
Ego depletion--is it all in your head? implicit theories about willpower affect self-regulation. Psychol Sci (2010) 2.19
The impact of stereotype threat on age differences in memory performance. J Gerontol B Psychol Sci Soc Sci (2003) 2.02
What Is Ego Depletion? Toward a Mechanistic Revision of the Resource Model of Self-Control. Perspect Psychol Sci (2012) 2.02
Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc (2003) 2.00
The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology (2003) 2.00
Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. J Clin Oncol (2012) 1.99
Attention control, memory updating, and emotion regulation temporarily reduce the capacity for executive control. J Exp Psychol Gen (2007) 1.99
The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn (2005) 1.91
Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat (2010) 1.89
Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol (2007) 1.88
Directed Attention as a Common Resource for Executive Functioning and Self-Regulation. Perspect Psychol Sci (2010) 1.82
Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response. J Cancer Surviv (2009) 1.81
A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol (2006) 1.79
Intellectual performance and ego depletion: role of the self in logical reasoning and other information processing. J Pers Soc Psychol (2003) 1.77
A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer (2005) 1.76
Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol (2007) 1.69
Development of an intervention to restore attention in cancer patients. Cancer Nurs (1993) 1.66
Knowing is half the battle: teaching stereotype threat as a means of improving women's math performance. Psychol Sci (2005) 1.66
Stigma as ego depletion: how being the target of prejudice affects self-control. Psychol Sci (2006) 1.60
Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist (2008) 1.57
Cognitive dysfunction in people with cancer. Lancet Oncol (2007) 1.47
Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Mapp (2011) 1.40
Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research. Neurosci Biobehav Rev (2010) 1.33
Why do women underperform under stereotype threat? Evidence for the role of negative thinking. Psychol Sci (2005) 1.28
Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep (2012) 1.23
Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors. Cancer (2010) 1.23
Pretreatment symptom distress in women newly diagnosed with breast cancer. Cancer Nurs (1999) 1.22
An environmental intervention to restore attention in women with newly diagnosed breast cancer. Cancer Nurs (2003) 1.18
Executive functions, self-regulation, and chronic pain: a review. Ann Behav Med (2009) 1.17
The skull beneath the skin: cancer survival and awareness of death. Psychooncology (2004) 1.17
Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Res Treat (2011) 1.16
Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis. Behav Brain Res (2011) 1.16
Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target. Br J Cancer (2004) 1.15
Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Eur J Oncol Nurs (2006) 1.12
Multiple social identities and stereotype threat: imbalance, accessibility, and working memory. J Pers Soc Psychol (2009) 1.12
The effects of stereotype threat on cognitive function in ecstasy users. J Psychopharmacol (2005) 1.11
Stereotype threat spillover: how coping with threats to social identity affects aggression, eating, decision making, and attention. J Pers Soc Psychol (2010) 1.11
Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial. Psychooncology (2010) 1.10
Mere effort and stereotype threat performance effects. J Pers Soc Psychol (2007) 1.05
Does rurality affect quality of life following treatment for breast cancer? J Rural Health (2010) 1.00
Perceptions of cancer as a death sentence: prevalence and consequences. J Health Psychol (2013) 1.00
Cancer and the threat of death: the cognitive dynamics of death-thought suppression and its impact on behavioral health intentions. J Pers Soc Psychol (2007) 0.98
Self-identity after cancer: "survivor", "victim", "patient", and "person with cancer". J Gen Intern Med (2009) 0.97
Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients. Psychooncology (2011) 0.96
Do tests of executive functioning predict ability to downregulate emotions spontaneously and when instructed to suppress? Cogn Affect Behav Neurosci (2009) 0.93
Cognitive dysfunction and cancer: which consequences in terms of disease management? Psychooncology (2011) 0.93
Self-regulatory processes defend against the threat of death: Effects of self-control depletion and trait self-control on thoughts and fears of dying. J Pers Soc Psychol (2006) 0.87
Stereotype threat strengthens automatic recall and undermines controlled processes in older adults. Psychol Sci (2012) 0.87
The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients. Psychooncology (2009) 0.86
The potential for neuropsychology to inform functional outcomes research with breast cancer survivors. NeuroRehabilitation (2006) 0.84
The role of prevention focus under stereotype threat: Initial cognitive mobilization is followed by depletion. J Pers Soc Psychol (2012) 0.83
Accumulating evidence for the effect of chemotherapy on cognition. J Clin Oncol (2012) 0.82
Considering the unspoken: the role of death cognition in quality of life among women with and without breast cancer. J Psychosoc Oncol (2012) 0.77
Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA (2009) 7.99
Adolescent males' awareness of and willingness to try electronic cigarettes. J Adolesc Health (2012) 4.05
Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial. Psychosom Med (2002) 2.97
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol (2011) 2.06
Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol (2004) 1.97
Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J Clin Oncol (2007) 1.94
Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat (2010) 1.89
Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp (2010) 1.83
The project ENABLE II randomized controlled trial to improve palliative care for rural patients with advanced cancer: baseline findings, methodological challenges, and solutions. Palliat Support Care (2009) 1.76
Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. J Clin Oncol (2010) 1.75
The self-efficacy of family caregivers for helping cancer patients manage pain at end-of-life. Pain (2003) 1.68
Feasibility study of a randomized controlled trial of a telephone-delivered problem-solving-occupational therapy intervention to reduce participation restrictions in rural breast cancer survivors undergoing chemotherapy. Psychooncology (2010) 1.65
Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Semin Clin Neuropsychiatry (2003) 1.53
Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. J Clin Oncol (2012) 1.49
Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer (2006) 1.48
Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav Brain Res (2007) 1.48
Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol (2012) 1.43
Cognitive-behavioral management of chemotherapy-related cognitive change. Psychooncology (2007) 1.41
Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Mapp (2011) 1.40
Don't derogate this message! Self-affirmation promotes online type 2 diabetes risk test taking. Psychol Health (2009) 1.39
Using mental imagery to deliver self-regulation techniques to improve sleep behaviors. Ann Behav Med (2013) 1.38
Partner-guided cancer pain management at the end of life: a preliminary study. J Pain Symptom Manage (2005) 1.36
An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol (2011) 1.32
Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry (2014) 1.30
Low neuropsychologic performance among adult cancer survivors treated with chemotherapy. Curr Neurol Neurosci Rep (2003) 1.30
What works best: objective statistics or a personal testimonial? An assessment of the persuasive effects of different types of message evidence on risk perception. Health Psychol (2008) 1.30
Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. J Infect (2012) 1.29
Neurocognitive changes in cancer survivors. Cancer J (2008) 1.27
Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep (2012) 1.23
Proxy perspectives regarding end-of-life care for persons with cancer. Cancer (2008) 1.21
Expressive disclosure and health outcomes in a prostate cancer population. Int J Psychiatry Med (2002) 1.17
Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study. Acta Oncol (2009) 1.17
Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Res Treat (2011) 1.16
Reliability and validity of the Functional Assessment of Chronic Illness Therapy-Palliative care (FACIT-Pal) scale. J Pain Symptom Manage (2008) 1.16
Impact on caregiver burden of a patient-focused palliative care intervention for patients with advanced cancer. Palliat Support Care (2010) 1.14
Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin (2014) 1.12
Cancer chemotherapy impairs contextual but not cue-specific fear memory. Behav Brain Res (2007) 1.11
Interpretations of smoking in film by older teenagers. Soc Sci Med (2003) 1.11
Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial. Psychooncology (2010) 1.10
Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments. Curr Psychiatry Rep (2004) 1.09
Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats. Behav Brain Res (2009) 1.08
Using new technologies to improve the prevention and management of chronic conditions in populations. Annu Rev Public Health (2015) 1.06
Sensitivity and specificity of the Distress Thermometer for depression in newly diagnosed breast cancer patients. Psychooncology (2008) 1.04
Do parents have any influence over how young people appraise tobacco images in the media? J Adolesc Health (2011) 1.04
Palliative care program effectiveness research: developing rigor in sampling design, conduct, and reporting. J Pain Symptom Manage (2006) 1.04
The influence of smoking imagery on the smoking intentions of young people: testing a media interpretation model. J Adolesc Health (2005) 1.03
A randomized, controlled trial of massage therapy as a treatment for migraine. Ann Behav Med (2006) 1.02
Differences between older and younger cancer survivors in seeking cancer information and using complementary/alternative medicine. J Gen Intern Med (2009) 1.02
Illness perceptions and COPD: an emerging field for COPD patient management. J Asthma (2008) 1.01
Effects of a creative expression intervention on emotions, communication, and quality of life in persons with dementia. Nurs Res (2010) 0.96
Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients. Psychooncology (2011) 0.96
Patient perspectives on participation in the ENABLE II randomized controlled trial of a concurrent oncology palliative care intervention: benefits and burdens. Palliat Med (2012) 0.96
Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia. Crit Rev Oncol Hematol (2013) 0.96
Using the common-sense model to predict risk perception and disease-related worry in individuals at increased risk for venous thrombosis. Health Psychol (2007) 0.95
Genetic pathway-based hierarchical clustering analysis of older adults with cognitive complaints and amnestic mild cognitive impairment using clinical and neuroimaging phenotypes. Am J Med Genet B Neuropsychiatr Genet (2010) 0.94
Is basic research providing answers if adjuvant anti-estrogen treatment of breast cancer can induce cognitive impairment? Life Sci (2013) 0.94
Disease detection or public opinion reflection? Content analysis of tweets, other social media, and online newspapers during the measles outbreak in The Netherlands in 2013. J Med Internet Res (2015) 0.93
Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release. Behav Brain Res (2009) 0.93
Graphic warning labels on plain cigarette packs: will they make a difference to adolescents? Soc Sci Med (2012) 0.92
Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type. Brain Imaging Behav (2015) 0.91
Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer. Clin Breast Cancer (2008) 0.91
Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy. Breast Cancer Res Treat (2005) 0.90
When god sanctions killing: effect of scriptural violence on aggression. Psychol Sci (2007) 0.90
Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy. Hum Brain Mapp (2012) 0.89
Non-smoking male adolescents' reactions to cigarette warnings. PLoS One (2013) 0.89
ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy. Clin Neurophysiol (2008) 0.88
How self-affirmation reduces defensive processing of threatening health information: evidence at the implicit level. Health Psychol (2009) 0.87
Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer. Menopause (2015) 0.87
The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients. Psychooncology (2009) 0.86
Predictors of Preoperative Weight Loss in Morbidly Obese Adults Waiting for Bariatric Surgery: A Prospective Cohort Study. Obes Surg (2015) 0.86
Inhibition of hippocampal cell proliferation by methotrexate in rats is not potentiated by the presence of a tumor. Brain Res Bull (2009) 0.86
Chemotherapy-induced amenorrhea: a prospective study of brain activation changes and neurocognitive correlates. Brain Imaging Behav (2013) 0.86
Emotional coping differences among breast cancer patients from an online support group: a cross-sectional study. J Med Internet Res (2014) 0.86
Emotional suppression tendencies as predictors of symptoms, mood, and coping appraisals during AC chemotherapy for breast cancer treatment. Ann Behav Med (2010) 0.86
Do Young Adults Perceive That Cigarette Graphic Warnings Provide New Knowledge About the Harms of Smoking? Ann Behav Med (2015) 0.86
Prevalence of self-reported memory problems in adult cancer survivors: a national cross-sectional study. J Oncol Pract (2011) 0.85
Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect? J Clin Oncol (2006) 0.85
Cognitive adverse effects of chemotherapy in breast cancer patients. Curr Opin Support Palliat Care (2007) 0.84
Emotional approach coping and the effects of online peer-led support group participation among patients with breast cancer: a longitudinal study. J Med Internet Res (2014) 0.84
Time since diagnosis as a predictor of symptoms, depression, cognition, social concerns, perceived benefits, and overall health in cancer survivors. Oncol Nurs Forum (2010) 0.82
Accumulating evidence for the effect of chemotherapy on cognition. J Clin Oncol (2012) 0.82
Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study. Clin Breast Cancer (2006) 0.82
Trait anxiety, information modality, and responses to communications about prenatal genetic testing. J Behav Med (2014) 0.81
A randomized trial of computer-based communications using imagery and text information to alter representations of heart disease risk and motivate protective behaviour. Br J Health Psychol (2011) 0.81
Incidental findings on brain Magnetic Resonance Imaging in long-term survivors of breast cancer treated with adjuvant chemotherapy. Eur J Cancer (2011) 0.81
Functional MRI studies in non-CNS cancers. Brain Imaging Behav (2013) 0.80
A pilot study of activity engagement in the first six months after stem cell transplantation. Oncol Nurs Forum (2011) 0.80
Reducing Decisional Conflict and Enhancing Satisfaction with Information among Women Considering Breast Reconstruction following Mastectomy: Results from the BRECONDA Randomized Controlled Trial. Plast Reconstr Surg (2016) 0.79
Ongoing distress from emotional trauma is related to pain, mood, and physical function in a primary care population. J Pain Symptom Manage (2003) 0.79
Do systemic cancer treatments affect cognitive function? Lancet Oncol (2004) 0.79
Advancing innovations in social/personality psychology and health: opportunities and challenges. Health Psychol (2013) 0.79
Promoting physical activity with goal-oriented mental imagery: a randomized controlled trial. J Behav Med (2011) 0.79
Development and initial evaluation of a telephone-delivered, behavioral activation, and problem-solving treatment program to address functional goals of breast cancer survivors. J Psychosoc Oncol (2015) 0.78
Human papillomavirus (HPV) vaccine acceptance and perceived effectiveness, and HPV infection concern among young New Zealand university students. Sex Health (2010) 0.78
Considering the unspoken: the role of death cognition in quality of life among women with and without breast cancer. J Psychosoc Oncol (2012) 0.77
Long-term effects of chemo on the cognitive function of cancer patients. Oncology (Williston Park) (2012) 0.76
Sustainability of behavioral interventions: beyond cost-effectiveness analysis. Int J Behav Med (2015) 0.76
The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy. Psychooncology (2010) 0.76
Comprehensive assessment of peri-operative fatigue: development of the Identity-Consequence Fatigue Scale. J Psychosom Res (2006) 0.76
Fatigue after colorectal surgery and its relationship to patient expectations. J Surg Res (2008) 0.76